Virtual Study Training from the Sponsor and Site Perspectives

• 

$79.00 (Non-Member Price)
$0.00 (SCRS members – Included as member benefit, no additional cost)

Not an SCRS member? Join now to attend this webinar at no additional cost.

Date and Time: April 13, 2021 @ 12:00 PM ET

Contact Hours: One contact hour will be issued.
Contact Hours are not available for archived webinars.

Presenters:

Robert Geckeler, Product Director, SMi Trial, ScienceMedia
Dr. Alexander Leedom, Medical Affairs R&D, Jazz Pharmaceuticals
MarieElena Cordisco, MA, NP-C, APRN, CCRC, AVP Clinical Trials, Nuvance Health
Michelle Hurst, RN, CCRC, Director of Operational Project Management, Meridian Clinical Research

Presented By: ScienceMedia

Description

Virtual training and site engagement tools are evolving to provide increasingly meaningful support for clinical research Investigators and study Sponsors. Join us for a discussion of how these platforms and the programs they deliver can facilitate trial conduct, enhance Site performance, and yield improved outcomes from the Sponsor and Site perspective.

Presenter  

Robert Geckeler, Product Director, SMi Trial, ScienceMedia
Robert has over 25 years of pharmaceutical industry experience spanning product formats and therapeutic areas while leading a range of global therapeutic development programs. Robert has served as Chief Development Officer for Sitka Biopharma and as a board member for Cerion NRx. Prior to that, he was VP of Operations at both Telephus Biosciences and Xenome Ltd. and led client services and product expansion at OneHealth. Robert has a B.A. in Biology from Washington University and an MBA from San Diego State University.

Alexander Leedom, Medical Affairs, Reearch & Development, Jazz Pharmaceuticals
Dr. Leedom attended the University of Southern California where he received his Bachelor of Science (BS) in Biology. Subsequently, Alex attended New York Medical College for both his Master of Science (MS) and PhD in Pharmacology.  He went on to complete two postdoctoral fellowships at UC Berkeley and Weil Cornell Medical College, where he studied the role of lipids in regulating inflammatory driven neovascularization.  Upon completion of his postdoctoral fellowships, Alex then went on to medical school, where he completed his MD.

After his training, Alex took a position at Bristol Myers Squibb (BMS) in R&D in, where he supported company-sponsored trials and ISTs in Lung (e.g., NSCLC, SCLC), Head & Neck, Breast, and GBM malignancies.  While at BMS, Alex launched two FDA approvals for OPDIVO (nivolumab) in metastatic small cell lung cancer (SCLC) as third-line treatment (August 2018) as well as in recurrent/metastatic squamous cell carcinoma of the head and neck (November 2016).  Alex went on to become an Associate Director in HQ Medical Affairs for Nektar Therapeutics and worked in a cross functional role with clinical development.  He helped to bring Nektar’s pegylated CD122 IL-2 agonist bempegaldesleukin (NKTR-214) compound (in combination with PD-1 inhibitors) to the clinic with Phase 2 trials in Lung, GU, and melanoma through strategic collaborations, negotiating contracts, and supporting clinical operations.  He currently is at Jazz pharmaceutical in medical affairs and moving into clinical development.

MarieElena Cordisco, MA, NP-C, APRN, CCRC, AVP, Clinical Trials Nuvance Health

Over her 15-year nurse practitioner career, MarieElena Cordisco, MA, APRN, NP-C, CCRC has been active in both clinical care and research.  She is an experienced family nurse practitioner with specialty in endocrinology.  Her current role is AVP of Clinical Trials at Nuvance Health. This health system is located in NY and CT, and has over 80 active clinical trials across all therapeutic areas. MarieElena is a strong advocate for increasing the role of nurse practitioners in clinical trials.  She is actively engaged on the leadership council for the Society of Clinical Research Sites, is the site liaison for her hospital network for the Clinical Trials Transformation Initiative, and sits on the nurse advisory council for Parexel.  She holds a Masters of Arts in Professorial Nursing, Post Graduate Certificate Nurse Practitioner and Certificate of Graduate Study Public Health.

Michelle Hurst, RN, CCRC, Director of Operations Project Management, Meridian Clinical Research
Director of Operational Project Management

Michelle Hurst is a registered nurse with a clinical background in critical care and neurology and has served in a number of clinical management roles, including managing a neurology practice.  In her current role as Director of Operational Project Management with Meridian Clinical Research, Hurst focuses on optimizing the performance and operational continuity across Meridian’s 23 sites. Before joining Meridian, Hurst was Director of Clinical Research at McKesson’s Intrafusion Research Network. At Intrafusion, Hurst developed and directed the company’s multi-specialty clinical research management program for more than 40 sites, including neurology, rheumatology, ophthalmology, and dermatology practices.

Society for Clinical Research Sites, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

To obtain your Contact Hours for this webinar:

1. The webinar must be watched in its entirety.
2. The post webinar survey immediately following this webinar must be completed in its entirety.
3. Your contact hour certificate will be sent to you within 30 days of you viewing this webinar.
4. The contact hour certificate will be sent to the email address provided when you registered.

Planners, presenters, faculty, authors, and content reviewers do not have any relevant financial relationships with any commercial interest.

This webinar does not imply any endorsement of products or services by the Society for Clinical Research Sites or ANCC.

The materials and recording of this webinar will be available for one year as an archive, but will not award any contact hours.

• Download iCalendar File
• View All Upcoming Events
• Go Home